SLC12A1
Solute carrier family 12 member 1
As of the edition of 20 October 2026, SLC12A1 (solute carrier family 12 member 1, UniProt Q13621) has 6 drugs tested at it and 36 companies on the list, 1 on route A and 3 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- Q13621
- How well studied
- Drug target: an approved drug acts on it
- Where it sits in the cell
- At a membrane
- Disease areas
- Heart and blood vessels; Urinary and reproductive; Pregnancy and women's health; Lungs and airways; Nutrition and metabolism; Inherited and neonatal; Cancer; Mental health
- Registered trials of its drugs
- 234
Drugs at this target
| Status | Count |
|---|---|
| Marketed | 5 |
| Went quiet | 1 |
| Total | 6 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| Furosemide | Marketed | Phase 4 | none listed |
| Torsemide | Marketed | Phase 4 | none listed |
| Bumetanide | Marketed | Phase 4 | none listed |
| Ethacrynic acid | Marketed | Phase 2 | none listed |
| CLS006 | Went quiet | Phase 3 | none listed |
| Piretanide | Marketed | No phase stated | none listed |
6 of 6 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Route A | 1 |
| Route B | 3 |
| Engaged | 2 |
| Undetermined | 30 |
| Total on the list | 36 |
| Company | Route |
|---|---|
| Proveca Pharma | Route B |
| Roche | Route B |
| Maruho | Route A |
The other 33 companies at SLC12A1
In the product36 companies in all; 33 are not named here, and no score is.
See the 36 companies at SLC12A1, ranked, with the facts behind eachRequest access. Nothing is shown until you do.